Trial · NCT06897553
ACT for Mental Health in Neurological Disorders
NCT06897553, Not applicable, Recruiting, Bielefeld University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. ACT for Mental Health in Neurological Disorders. Trials, record NCT06897553. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06897553
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- ACT for Mental Health in Neurological Disorders
- NCT number
- NCT06897553
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 44 participants, estimated
- Lead sponsor
- Bielefeld University
- Conditions
- Neurological Disorders, Mental Health, Executive Function (Cognition), Depression/Anxiety, Stress, Brain Injury, Post-COVID
- Interventions
- ACT-based group therapy
- First posted
- 2025-03-27
- Last updated
- 2025-03-27
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Depression and Anxiety Stress Scales-21 (Lovibond, 1995) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of psychological burden to investigate efficacy. Scores range from 0 to 63 with higher values indicating higher burden. |
| Primary | Acceptance and Action Questionnaire-Acquired Brain Injury (Sylvester, 2011) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of psychological flexibility to investigate efficacy. Scores range from 0 to 36 with higher values indicating higher inflexibility. |
| Primary | Wechsler Adult Intelligence Scale - Fourth Edition (Similarities subtest; Wechsler, 2008) | pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of individual's ability to recognize and articulate the commonalities between different objects, reflecting their abstraction ability. This will be used to examine the influence of the ability of abstract thinking. Scores range from 0 to 36 with higher values indicating higher ability of abstraction. |
| Secondary | Patient Health Questionnaire-9 (Kroenke, 2001) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of depressive symptoms to investigate efficacy. Scores range from 0 to 27 with higher values indicating more severe depressive symptoms. |
| Secondary | Generalized Anxiety Disorder Scale-7 (GAD-7; Spitzer et al., 2007) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of anxiety symptoms to investigate efficacy. Scores range from 0 to 21 with higher scores indicating higher anxiety. |
| Secondary | Valuing Questionnaire (Smout, 2014) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of valued living to investigate efficacy. Scores range from 0 to 60 with higher values indicating higher value-congruent living. |
| Secondary | Self-as-context scale (Zettle, 2018) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of self as context to investigate efficacy. Scores range from 10 to 70 with higher values indicating a perspective closer to self-as-context. |
| Secondary | World Health Organization Disability Assessment Schedule 2.0 (V.S. Üstün, 2010; Plain German) | Before waiting list condition; and pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of functional impairments and disabilities. |
| Secondary | Regensburg Word Fluency Test (Aschenbrenner, 2001) | pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of verbal fluency. |
| Secondary | Stroop Test in Vienna Test System (Müller & Ziegler, 2001) | pre- and post-intervention (pre and post are presumably 8 weeks apart) | Measure of cognitive flexibility and inhibition of irrelevant stimuli. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06897553
GET https://conductscience.org/api/trials/v1/NCT06897553/registered